Modeling the economic outcomes of immuno-oncology drugs: alternative model frameworks to capture clinical outcomes
EJ Gibson,1 N Begum,1 I Koblbauer,1 G Dranitsaris,2 D Liew,3 P McEwan,4 AA Tahami Monfared,5,6 Y Yuan,7 A Juarez-Garcia,7 D Tyas,8 M Lees9 1Wickenstones Ltd, Didcot, UK; 2Augmentium Pharma Consulting Inc, Toronto, ON, Canada; 3Department of Epidemiology and Preventive Medicine, Alfred Hospital, Mona...
Saved in:
Main Authors: | Gibson EJ (Author), Begum N (Author), Koblbauer I (Author), Dranitsaris G (Author), Liew D (Author), McEwan P (Author), Tahami Monfared AA (Author), Yuan Y (Author), Juarez-Garcia A (Author), Tyas D (Author), Lees M (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2018-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Economic Evaluation of Single versus Combination Immuno-Oncology Therapies: Application of a Novel Modelling Approach in Metastatic Melanoma
by: Gibson EJ, et al.
Published: (2020) -
The Role of Mathematical Models in Immuno-Oncology: Challenges and Future Perspectives
by: Aymara Sancho-Araiz, et al.
Published: (2021) -
Strategic Consensus on the Value of Immuno-Oncology in Portugal
by: . .
Published: (2016) -
Real-world use and clinical impact of an electronic patient-reported outcome tool in patients with solid tumors treated with immuno-oncology therapy
by: Natalie R Dickson, et al.
Published: (2024) -
Concepts for agonistic targeting of CD40 in immuno-oncology
by: David M. Richards, et al.
Published: (2020)